IgE (Omalizumab Biosimilar) Antikörper
(IgE (Omalizumab Biosimilar))
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene IgE (Omalizumab Biosimilar) Antikörper
Neueste Publikationen zu unseren IgE (Omalizumab Biosimilar) Produkten
: "Optimisation of omalizumab dosage in patients with severe persistent allergic asthma using recoveryELISA." in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, Vol. 28, Issue 5, pp. 445-50, (2014) (PubMed).: "Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22." in: Current medical research and opinion, Vol. 30, Issue 10, pp. 1923-5, (2014) (PubMed).
: "The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab." in: Journal of immunoassay & immunochemistry, Vol. 34, Issue 1, pp. 83-93, (2013) (PubMed).
: "The recoveryELISA--a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy." in: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 50, Issue 7, pp. 1263-9, (2012) (PubMed).
: "Monitoring free serum IgE in severe asthma patients treated with omalizumab." in: Respiratory medicine, Vol. 106, Issue 11, pp. 1494-500, (2012) (PubMed).